Article
Connexin 47 mutations increase risk for secondary lymphedema following breast cancer treatment.
Clinical cancer research : an official journal of the American Association for Cancer Research - 15 Apr 2012
Finegold David N, Baty Catherine J, Knickelbein Kelly Z, Perschke Shelley, Noon Sarah E, Campbell Diana, Karlsson Jenny M, Huang Diana, Kimak Mark A, Lawrence Elizabeth C, Feingold Eleanor, Meriney Stephen D, Brufsky Adam M, Ferrell Robert E
Abstract excerpt
PURPOSE: Secondary lymphedema is a frequent complication of breast cancer associated with surgery, chemotherapy, or radiation following breast cancer treatment. The potential contribution of genetic susceptibility to risk of developing secondary lymphedema following surgical trauma, radiation, and other tissue insults has not been studied. EXPERIMENTAL DESIGN: To determine whether women with breast cancer and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.